Dilip Kumar Singh

602 total citations
54 papers, 409 citations indexed

About

Dilip Kumar Singh is a scholar working on Pharmacology, Molecular Biology and Analytical Chemistry. According to data from OpenAlex, Dilip Kumar Singh has authored 54 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 12 papers in Molecular Biology and 12 papers in Analytical Chemistry. Recurrent topics in Dilip Kumar Singh's work include Pharmacogenetics and Drug Metabolism (18 papers), Analytical Methods in Pharmaceuticals (12 papers) and Drug Transport and Resistance Mechanisms (11 papers). Dilip Kumar Singh is often cited by papers focused on Pharmacogenetics and Drug Metabolism (18 papers), Analytical Methods in Pharmaceuticals (12 papers) and Drug Transport and Resistance Mechanisms (11 papers). Dilip Kumar Singh collaborates with scholars based in United States, India and China. Dilip Kumar Singh's co-authors include Saranjit Singh, Archana Sahu, Anjana Goel, George G. Yarbrough, Sandeep Kumar, Moolchand Kurmi, Bhagwat Prasad, M. N. V. Ravi Kumar, Mukesh C. Sharma and Sanjeev Giri and has published in prestigious journals such as Biochemical Journal, Journal of Pharmacology and Experimental Therapeutics and Cellular and Molecular Life Sciences.

In The Last Decade

Dilip Kumar Singh

49 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dilip Kumar Singh United States 13 103 92 79 69 58 54 409
Jan Felix Joseph Germany 13 189 1.8× 78 0.8× 140 1.8× 46 0.7× 47 0.8× 23 599
Naveen Sharma India 14 91 0.9× 155 1.7× 84 1.1× 46 0.7× 112 1.9× 27 485
Valquíria Aparecida Polisel Jabor Brazil 17 164 1.6× 90 1.0× 187 2.4× 85 1.2× 91 1.6× 34 630
Yu‐Luan Chen United States 14 212 2.1× 131 1.4× 302 3.8× 72 1.0× 63 1.1× 34 625
Hironori Yoshitomi Japan 13 110 1.1× 61 0.7× 42 0.5× 84 1.2× 54 0.9× 37 424
Chunxiao Lv China 16 321 3.1× 62 0.7× 42 0.5× 118 1.7× 51 0.9× 32 603
Unyong Kim South Korea 13 251 2.4× 89 1.0× 93 1.2× 76 1.1× 57 1.0× 23 436
Shuping Wang China 12 151 1.5× 56 0.6× 38 0.5× 36 0.5× 54 0.9× 23 500
Timo Mauriala Finland 19 352 3.4× 98 1.1× 294 3.7× 66 1.0× 53 0.9× 22 896
Yan Shi China 18 267 2.6× 84 0.9× 175 2.2× 51 0.7× 73 1.3× 76 796

Countries citing papers authored by Dilip Kumar Singh

Since Specialization
Citations

This map shows the geographic impact of Dilip Kumar Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dilip Kumar Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dilip Kumar Singh more than expected).

Fields of papers citing papers by Dilip Kumar Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dilip Kumar Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dilip Kumar Singh. The network helps show where Dilip Kumar Singh may publish in the future.

Co-authorship network of co-authors of Dilip Kumar Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Dilip Kumar Singh. A scholar is included among the top collaborators of Dilip Kumar Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dilip Kumar Singh. Dilip Kumar Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Dilip Kumar, et al.. (2025). Is N1-Methylnicotinamide a Good Organic Cation Transporter 2 (OCT2) Biomarker?. Metabolites. 15(2). 80–80. 1 indexed citations
2.
Singh, Dilip Kumar, et al.. (2025). Quantitative Contributions of Hepatic and Renal Organic Cation Transporters to the Clinical Pharmacokinetic Cimetidine–Metformin Interaction. Clinical Pharmacology & Therapeutics. 118(2). 343–354. 2 indexed citations
4.
Singh, Dilip Kumar, et al.. (2025). Effects of Chronic Alcohol Intake on the Composition of the Ensemble of Drug-Metabolizing Enzymes and Transporters in the Human Liver. Journal of Xenobiotics. 15(1). 20–20. 2 indexed citations
7.
Singh, Dilip Kumar, et al.. (2024). Differential Tissue Abundance of Membrane-Bound Drug Metabolizing Enzymes and Transporter Proteins by Global Proteomics. Drug Metabolism and Disposition. 52(11). 1152–1160. 8 indexed citations
9.
Paquette, Alison G., Dilip Kumar Singh, James W. MacDonald, et al.. (2023). Characterization of Xenobiotic and Steroid Disposition Potential of Human Placental Tissue and Cell Lines (BeWo, JEG-3, JAR, and HTR-8/SVneo) by Quantitative Proteomics. Drug Metabolism and Disposition. 51(8). 1053–1063. 4 indexed citations
11.
Singh, Dilip Kumar, et al.. (2023). Effect of Cimetidine on Metformin Pharmacokinetics and Endogenous Metabolite Levels in Rats. Drug Metabolism and Disposition. 52(2). 86–94. 5 indexed citations
12.
Singh, Dilip Kumar, et al.. (2023). High-Resolution Mass Spectrometry Coupled with XCMS Online for High-throughput Detection and Identification of Drug Metabolites. Journal of Pharmacology and Experimental Therapeutics. 385. 182–182. 1 indexed citations
13.
Sharma, S.C., Abdul Basit, Christina Wang, et al.. (2022). Dimethandrolone, a Potential Male Contraceptive Pill, is Primarily Metabolized by the Highly Polymorphic UDP-Glucuronosyltransferase 2B17 Enzyme in Human Intestine and Liver. Drug Metabolism and Disposition. 50(12). 1493–1500. 6 indexed citations
14.
Sahu, Archana, et al.. (2021). Characterization of degradation products of celiprolol hydrochloride using hyphenated mass and NMR techniques. Journal of Pharmaceutical and Biomedical Analysis. 197. 113953–113953. 5 indexed citations
15.
Singh, Dilip Kumar, Archana Sahu, Aabid A. Wani, et al.. (2020). Characterization of Photodegradation Products of Bepotastine Besilate and In Silico Evaluation of Their Physicochemical, Absorption, Distribution, Metabolism, Excretion and Toxicity Properties. Journal of Pharmaceutical Sciences. 109(6). 1883–1895. 17 indexed citations
17.
Singh, Dilip Kumar, Archana Sahu, Aabid A. Wani, et al.. (2019). Stability behaviour of antiretroviral drugs and their combinations. 10: LC-HRMS, LC-MSn, LC-NMR and NMR characterization of fosamprenavir degradation products and in silico determination of their ADMET properties. European Journal of Pharmaceutics and Biopharmaceutics. 142. 165–178. 16 indexed citations
18.
Srivastava, Sarita, et al.. (2014). Development of a spectrofluorimetric method forthe determination of quercetin. 亚洲传统医药. 9(6). 136–142. 2 indexed citations
19.
Goel, Anjana, Dilip Kumar Singh, & Anil Bhatia. (2010). Effect of Ocimum sanctum extract on the induction of IFN-γ and IL-10 cytokines and their m-RNA expression. 12(1). 29–41. 4 indexed citations
20.
Swarnkar, C.P., et al.. (2008). Potential of alcoholic extract of Azadirachta indica bark as anthelmintic in sheep. Journal of Veterinary Parasitology. 22(2). 13–16. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026